Travaux scientifiques

Prof. Dr. Aydoğan Aydoğdu

144 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler (sözel-poster)

    Source : page de profil sur medicana.com.tr

  2. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler

    Source : page de profil sur medicana.com.tr

  3. 1.Tasci I, Cintosun U, Safer U, Naharci MI, Bozoglu E, Aydogdu A, Doruk H. Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study. Acta Clin Belg. 2018;73:237-243.

    Source : page de profil sur medicana.com.tr

  4. 2.Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome. Haymana C, Aydogdu A, Demirci I, Dinc M, Demir O, Torun D, Yesildal F, Meric C, Basaran Y, Sonmez A, Azal O. Endocr Metab Immune Disord Drug Targets. 2018;18(4):401-406.

    Source : page de profil sur medicana.com.tr

  5. 3.Haymana C, Aydoğdu A, Soykut B, Erdem O, Ibrahimov T, Dinc M, Meric C, Basaran Y, Sonmez A, Azal O., Oxidative stress status in congenital hypogonadism: an appraisal. Toxicol Mech Methods. 2017 May 2:1-7. doi: 10.1080/15376516.2017.1320693.

    Source : page de profil sur medicana.com.tr

  6. 4.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Taslipinar A, Yilmaz MI, Azal O., Effect of Testosterone Replacement Therapy on Vitamin D and FGF-23 Levels in Congenital Hypogonadism. Endokrynol Pol. 2017 Feb 23. doi: 10.5603/EP.a2017.0009

    Source : page de profil sur medicana.com.tr

  7. 5.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism. Arch Endocrinol Metab. 2017 Feb 13:0. doi: 10.1590/2359-3997000000236.

    Source : page de profil sur medicana.com.tr

  8. 6.Sönmez A, Dinç M, Taşlıpınar A, Aydoğdu A, Meriç C, Başaran Y, Haymana C, Demir O, Yılmaz İ, Azal Ö. Add on Exenatide Treatment is Beneficial in Poorly Controlled Obese Type 2 Diabetics under Intensive Insulin Regimens. Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):256-261

    Source : page de profil sur medicana.com.tr

  9. 7.Aydogdu A, Swerdloff RS. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs. 2016 Sep;21(3):255-66

    Source : page de profil sur medicana.com.tr

  10. 8.Tasci I, Safer U, Cintosun U, Bozoglu E, Naharci I, Aydogdu A, Meric C, Doruk H. Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis. Endocr Metab Immune Disord Drug Targets. 2016;16(1):32-8.

    Source : page de profil sur medicana.com.tr

  11. 9.Bayram F, Elbuken G, Korkmaz C, Aydogdu A, Karaca Z, Cakır I. The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism. Horm Metab Res. 2016 Feb;48(2):112-7.

    Source : page de profil sur medicana.com.tr

  12. 10.Aydogdu A, Haymana C, Soykut B, Erdem O, Basaran Y, Baskoy K, Dinc M, Taslipinar A, Sonmez A, Bolu E, Azal O. Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biol Trace Elem Res. 2016 May;171(1):26-32.

    Source : page de profil sur medicana.com.tr

  13. 11.Sonmez A, Haymana C, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement. Endocr J. 2015;62(7):605-13.

    Source : page de profil sur medicana.com.tr

  14. 12.Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism. Meric C, Sonmez A, Aydogdu A, Tapan S, Haymana C, Basaran Y, Baskoy K, Sertoglu E, Taslipinar A, Bolu E, Azal O. Horm Metab Res. 2014; 46: 955-958.

    Source : page de profil sur medicana.com.tr

  15. 13.Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene. Aydogdu A, Haymana C, Baskoy K, Durukan AH, Ozgur G, Azal O. J Res Med Sci. 2014;19: 75-79.

    Source : page de profil sur medicana.com.tr

  16. 14.Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease. Doğaner YÇ, Aydoğan Ü, Rohrer JE, Aydoğdu A, Çaycı T, Barçın C, Sağlam K. Anadolu Kardiyol Derg. 2014; 16. doi: 10.5152/akd.2014.5535.

    Source : page de profil sur medicana.com.tr

  17. 15.Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. Meriç C, Aydoğdu A, Taşçı İ, Deniz F, Baysan O, Serdar M, Sağlam K, Azal Ö. Anadolu Kardiyol Derg. 2014; 14: 234-238.

    Source : page de profil sur medicana.com.tr

  18. 16.Relationship of cystatin C with coronary artery disease and its severity. Doganer YC, Aydogan U, Aydogdu A, Aparci M, Akbulut H, Nerkiz P, Turker T, Cayci T, Barcin C, Saglam K. Coron Artery Dis. 2013; 24: 119-126.

    Source : page de profil sur medicana.com.tr

  19. 17.The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A. Arch Pharm Res. 2013 Aug 8.

    Source : page de profil sur medicana.com.tr

  20. 18.Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes. Tasci I, Naharci MI, Bozoglu E, Safer U, Aydogdu A, Yilmaz BF, Yilmaz G, Doruk H. Endocr Metab Immune Disord Drug Targets. 2013; 13: 256-263.

    Source : page de profil sur medicana.com.tr

  21. 19.HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism. Bolu E, Sonmez A, Tapan S, Taslipinar A, Aydogdu A, Meric C, Basaran Y, Uckaya G, Serdar M, Kurt I, Azal O. Horm Metab Res. 2013; 45: 443-448.

    Source : page de profil sur medicana.com.tr

  22. 20.Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience. Aydogdu A, Bolu E, Sonmez A, Tasci I, Haymana C, Acar R, Meric C, Taslipinar A, Ozgurtas T, Azal O. Clin Endocrinol (Oxf). 2013; 79: 243-251.

    Source : page de profil sur medicana.com.tr

  23. 21.Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases. Taşçı İ, Kabul HK, Aydoğdu A. Anadolu Kardiyol Derg. 2012; 12: 684-688.

    Source : page de profil sur medicana.com.tr

  24. 22.Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K. Endocr J. 2012; 59: 1099-1105.

    Source : page de profil sur medicana.com.tr

  25. 23.Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Aydogdu A, Tasci I, Kucukerdonmez O, Tapan S, Aydogdu S, Aydogan U, Sonmez A, Yazici M, Azal O. Gynecol Endocrinol. 2013 Feb;29(2):152-5.

    Source : page de profil sur medicana.com.tr

  26. 24.Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? Aydogdu A, Tasci I, Tapan S, Sonmez A, Aydogan U, Akbulut H, Uckaya G, Aydogdu S, Basaran Y, Meric C, Taslipinar A, Kurt I, Azal O. Exp Clin Endocrinol Diabetes. 2012; 120: 261-265.

    Source : page de profil sur medicana.com.tr

  27. 25.The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Aydogdu A, Uckaya G, Tasci I, Baysan O, Tapan S, Bugan B, Serdar M, Akbulut H, Aydogan U, Sonmez A, Aydogdu S, Kutlu M. Endocr J. 2012; 59: 509-16.

    Source : page de profil sur medicana.com.tr

  28. 26.Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome. Dogan MI, Tasci I, Bulucu F, Aydogdu A, Acar R, Ceyhan T, Koc B, Demir O, Gezer M, Saglam K. Angiology. 2013; 64: 105-11.

    Source : page de profil sur medicana.com.tr

  29. 27.High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O. Gynecol Endocrinol. 2012; 28: 722-725.

    Source : page de profil sur medicana.com.tr

  30. 28.Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. Sonmez A, Haymana C, Bolu E, Aydogdu A, Tapan S, Serdar M, Altun B, Barcin C, Taslipinar A, Meric C, Uckaya G, Kutlu M. Eur J Endocrinol. 2011 May;164(5):759-64.

    Source : page de profil sur medicana.com.tr

  31. 29.Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M. Endocrine. 2010; 37: 455-459.

    Source : page de profil sur medicana.com.tr

  32. 30.The accuracy of home glucosemeters in hypoglycemia. Sonmez A, Yilmaz Z, Uckaya G, Kilic S, Tapan S, Taslipinar A, Aydogdu A, Yazici M, Yilmaz MI, Serdar M, Erbil MK, Kutlu M. Diabetes Technol Ther. 2010; 12: 619-626.

    Source : page de profil sur medicana.com.tr

  33. 31.HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities. Taslipinar A, Kebapcilar L, Kutlu M, Sahin M, Aydogdu A, Uckaya G, Azal O, Bolu E, Ibrahim Aydin H. Intern Med. 2008;47(11):1003-7.

    Source : page de profil sur medicana.com.tr

  34. 32.The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Kucukardali Y, Aydogdu S, Ozmen N, Yonem A, Solmazgul E, Ozyurt M, Cingozbay Y, Aydogdu A. Cardiovasc Revasc Med. 2008; 9: 66-70.

    Source : page de profil sur medicana.com.tr

  35. 33.Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y. Int J Clin Pract. 2008; 62: 754-761.

    Source : page de profil sur medicana.com.tr

  36. 1.U. Aydoğan, H Akbulut, D.E. Gök, Y. C. Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, The 3rd Eurasia Congress Of İnfectious Diseases konferansı dahilinde "Congress Book and Abstracts" bildiri kitapçığındaki "The prevalance of anti-HCV and HbsAg ın hemodialysis patients. The 3rd Eurasia Congress Of Infectious Diseases", 208 pp., Bakü, Azerbeycan, 01-04 Ekim 2009

    Source : page de profil sur medicana.com.tr

  37. 2.U. Aydoğan, H. Akbulut, D.E. Gök, Y. C. Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, The 3rd Eurasia Congress Of İnfectious Diseases konferansı dahilinde "Congress Book and Abstracts" bildiri kitapçığındaki "Hemodialysis patients carrying nasal staphylococcus aureus and meticilin resistance.", 207 pp., Bakü, Azerbeycan, Ekim 2009

    Source : page de profil sur medicana.com.tr

  38. 3.A. Sönmez, Z. Yılmaz, G. Üçkaya, S. Tapan, A. Taşlıpınar, A. Aydoğdu, M. Yazıcı, H. Turan, E. Bolu, O. Azal, A. Çorakçı, M. Kutlu., 20th World Diabetes Congress konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Are glucometers sensitive enough to detect hypoglycemia?", 379 pp., Montreal, Kanada, Ekim 2009

    Source : page de profil sur medicana.com.tr

  39. 4.A. Aydoğdu, H. Akbulut, G. Üçkaya, A. Taşlıpınar, A. Sönmez, U. Aydoğan, M. Kutlu, 12th European Congress Of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Carcaneal spur ıncidence ıs ıncreased ın patients with type 2 diabetes mellitus", p320 pp., Prag, Çek Cumhuriyeti, Nisan, 2010

    Source : page de profil sur medicana.com.tr

  40. 5.A. Aydoğdu, Ö. Küçükerdönmez, G. Üçkaya, A. Taşlıpınar, E. Bolu, A. Sönmez, U. Aydoğan, M. Kutlu, 12th European Congress Of Endocrinology, konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Waist circumference does not reflect body fat distribution and insulin resistance ın young male patients with idiopathic hypogonadotropic Hypogonadism", p697 pp., Prag, Çek Cumhuriyeti, Nisan 2010

    Source : page de profil sur medicana.com.tr

  41. 6.A. Sönmez, C. Haymana, E. Bolu, S. Tapan, C. Barçın, A. Aydoğdu, A.Taşlıpınar, M. Kutlu, 12th European Congress Of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Searching for the metabolic syndrome criteria ın young adults with hypogonadism", P148 pp., Prag, Çek Cumhuriyeti, Nisan 2010

    Source : page de profil sur medicana.com.tr

  42. 7.M.Y. Yarpuz, U. Aydoğan, O. Sarı, A. Aydoğdu, G . Üçkaya, K. Sağlam., 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "The effect of thyroid replacement therapy to levels of anxiety and depression in subclinical hypothyroid patients.", 198 pp., Antalya, Türkiye, Nisan 2010

    Source : page de profil sur medicana.com.tr

  43. 8.U. Aydoğan H. Akbulut, A. Parlak, O. Sarı, A. Aydoğdu, C. Barçın, K. Sağlam., 19th Wonca World Conference of Family Doctors konferansı dahilinde "Abstracts" bildiri kitapçığındaki "Coronary artery disease, comorbid diseases and pharmaceutical drug usage.", 384 pp., Cancun, Meksika, Mayıs 2010

    Source : page de profil sur medicana.com.tr

  44. 9.U. Aydoğan, H. Akbulut, A. Aydoğdu, Y.C. Doğaner, E. Bolu, K. Sağlam, 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "Complications and comorbid diseases in type 2 diabetic patients.", 221 pp., Antalya, Türkiye, Nisan 2010

    Source : page de profil sur medicana.com.tr

  45. 10.A. Aydoğdu, U. Aydoğan, H. Akbulut, O. Sarı, E. Bolu, K. Sağlam., 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe konferansı dahilinde "Abstracts' Book" bildiri kitapçığındaki "Anxiety levels ın patients diagnosed with and being treated for hypogonadism.", 221 pp., Antalya, Türkiye, Nisan 2010

    Source : page de profil sur medicana.com.tr

  46. 11.A. Aydoğdu, S. Aydoğdu, U. Aydoğan, C. Meriç, H. Akbulut, S. Yüksel, O. Sarı, G. Üçkaya, A. Sönmez, A. Taşlıpınar, M. Kutlu., 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "The frequency of prediabetes and diabetes mellitus in young obese male adolescents", 57 pp., İstanbul, Türkiye, Nisan 2011

    Source : page de profil sur medicana.com.tr

  47. 12.H. Akbulut, U. Aydoğan, A. Aydoğdu, P. Nerkiz, C. Barçın, Y.C. Doğaner, T. Türker, K. Sağlam., 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Comparison of the results of elective angiography with exercise stress testing results", 56 pp., İstanbul, Türkiye, Nisan 2011

    Source : page de profil sur medicana.com.tr

  48. 13.Y.C. Doğaner, U. Aydoğan, A. Aydoğdu, P. Nerkiz, O. Sarı, H. Akbulut, C. Barçın, K. Sağlam, K. 2nd International Meeting Of Hypertension And Diabetes Primary Care konferansı dahilinde "Abstract Book" bildiri kitapçığındaki "Relationship between diabetes mellitus and coronary artery disease", 53 pp., İstanbul, Türkiye, Nisan 2011

    Source : page de profil sur medicana.com.tr

  49. 14.A. Sonmez, C. Haymana, E. Bolu, A. Aydogdu, S. Tapan, M. Serdar, B. Altun, C. Barcin, A. Taslipinar, C. Meric, G. Uckaya, M. Kutlu., 13th European Congress of Endocrinology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Metabolic Syndrome and the effect of testosterone treatment in young men with hypogonadotropic hypogonadism", P562 pp., Rotterdam, Hollanda, Nisan 2011

    Source : page de profil sur medicana.com.tr

  50. 15.A. Aydogdu, G. Uckaya, I. Tascı, O. Baysan, S. Tapan, B. Bugan, M. Serdar, S. Aydogdu, H. Akbulut, U. Aydogan, A. Sonmez, O. Azal, 15th Internatıonal, 14th European Congrees of Endocrınology konferansı dahilinde "Endocrine Abstracts" bildiri kitapçığındaki "Epicardial adipose tissue thickness in patients with polycystic ovary syndrome", p963 pp., Floransa, İtalya, Mayıs 2012

    Source : page de profil sur medicana.com.tr